Coronary heart disease (CHD) is one of the most common heart diseases worldwide and is currently grouped into two syndromes: acute coronary syndrome (ACS) and chronic coronary syndrome (CCS). Following revascularization, patients with ACS and CCS are usually treated in the medium and long term by both general practitioners and cardiologists. The current guidelines of the European Society of Cardiology (ESC) emphasize that the assessment of the individual ischemia and bleeding risk is an important basis for the choice of an adequate antithrombotic strategy.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- Chronic musculoskeletal pain
How can the use of analgesics be optimized in multimodal therapy?
- Interview with Prof. Thomas Kündig (USZ)
“If we control itching and eczema, a normal life is possible again”
- From symptom to diagnosis
Abdominal pain – groin pain: internal causes
- Chronic pain
Nano-ECS modulator Adezunap improves therapy success
- Psoriasis and PsA
Biologics, oral peptide and trivalent nanobody – current results and trends
- Cancer in Europe: facts and analysis
New Health Policy Report published
- Gastrointestinal complaints
PPI regulation under the microscope
- Wound management: clinical diagnostics